GZMB and secondary progressive multiple sclerosis: Using our longitudinal analysis, which involved a 6-monthly collection of serum samples, we were able to show that changes in granzyme B and immune-associated miRNA patterns mark the conversion to secondary progressive multiple sclerosis.